SCHEMBL28051164

SCHEMBL28051164

COc1cc(N)c(C(=O)OC/C=C/c2ccccc2)cc1OC

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.51
▸ CACNA1B Q00975 8/20 0.47
▸ MMP1 P03956 1/20 0.46
▸ MMP2 P08253 1/20 0.46
▸ MMP9 P14780 1/20 0.46
▸ MMP12 P39900 1/20 0.46
▸ MAPT P10636 3/20 0.44
▸ EGFR P00533 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ TNFRSF1A P19438 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28051165 1.00 KDM4E (0.51) KDM4ECACNA1BMMP1MMP2MMP9
SCHEMBL8164747 0.81 MMP1 (0.49) CACNA1BMMP1MMP2MMP9MMP12
Cinnamyl Anthranilate SCHEMBL826957 0.80 ALDH1A1 (0.63) KDM4ECACNA1BMMP1MMP2MMP9
Cinnamyl Anthranilate SCHEMBL826956 0.80 ALDH1A1 (0.63) KDM4ECACNA1BMMP1MMP2MMP9
Cinnamyl Anthranilate SCHEMBL14764170 0.80 ALDH1A1 (0.63) KDM4ECACNA1BMMP1MMP2MMP9
SCHEMBL8788521 0.77 KDM4E (0.61) KDM4EALDH1A1KMT2A
SCHEMBL27669917 0.77 MMP1 (0.45) KDM4ECACNA1BMMP1MMP2MMP9
Cinnamyl Anthranilate SCHEMBL9957169 0.76 ALDH1A1 (0.58) KDM4ECACNA1BMMP1MMP2MMP9
SCHEMBL5132345 0.75 HSD17B2 (0.59) KDM4ECACNA1BMAPTEGFRALDH1A1
SCHEMBL5132344 0.75 HSD17B2 (0.59) KDM4ECACNA1BMAPTEGFRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105294471-A Synthetic method of alpha-amido-gamma-nitro succinate derivative UNIV EAST CHINA NORMAL 2016-02-03 — — CN disclosed
Send feedback